Immunic, Inc., a clinical-stage biopharmaceutical company focused on developing potentially best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, announced the appointment of Sanjay S. Patel, CFA, as Chief Financial Officer, effective July 15, 2019. Sanjay Patel replaces Tamara A. Seymour, who has served as the company’s Interim Chief Financial Officer since April 2019. “With a deep well of C-Suite and investment banking experience, Sanjay’s proven track record, strong knowledge base and established industry relationships will be especially important to us,” stated Daniel Vitt, PhD, Chief Executive Officer and President of Immunic. From 2014 to 2016 Patel served as Chief Financial Officer of Pernix Therapeutics Holdings, Inc. He was Managing Director, Healthcare Investment Banking at Cantor Fitzgerald from 2009 ­to 2014.